Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlumasc Group Regulatory News (ALU)

Share Price Information for Alumasc Group (ALU)

Share Price is delayed by 15 minutes
Get Live Data
240.00    5.00 (2.13%)
Bid:
235.00
Ask:
245.00
Spread: 10.00 (4.255%)
Market Cap: £86.30m
ALU Live PriceLast checked at - London Stock Exchange

Intraday Alumasc Group Share Chart

Trading Statement

14 Mar 2018 07:00

RNS Number : 6253H
Alumasc Group PLC
14 March 2018
 

IMMEDIATE RELEASE 14 March 2018

 

The Alumasc Group plc (ALU.L) ("Alumasc" or the "group")

 

Trading Statement

 

Alumasc has so far experienced a slower than expected third quarter performance, both in terms of revenue and order intake. The principal reasons are macro-economic and industry specific:

· continuing delays in building contractor customers committing to new work following recent margin pressures, exacerbated in January by the insolvency of Carillion and the consequential impact across the industry;

· broader economic and political uncertainties impacting demand particularly in the commercial new build sector, with recent reports of construction output in this sector showing decline;

· delays to public housing refurbishment contracts in Scotland; and

· severe winter weather over the last few weeks.

These issues have had an impact particularly on Levolux's UK Solar Shading business, the Roofing & Walling division and the Gatic business within the Water Management division. It is likely that the first three of these factors will also impact the group's final quarter performance.

In contrast, areas where Alumasc's products and systems are sold via building distribution channels continue to perform well, with revenue growth remaining ahead of UK construction market growth at Alumasc Water Management Solutions, Rainclear and Timloc.

In view of all the above, the Board's latest forecasts are that group revenues for the year ending 30 June 2018 will be 4-5% below previous expectations, with a consequential reduction in previously expected underlying profit before tax of around 15%.

The integration of Wade, the specialist drainage business acquired by Alumasc on 1 February 2018, is progressing well and the Board believes that potential synergies as part of Alumasc's broader Water Management division and its "rain to drain" strategy are significant.

Whilst Alumasc is not immune to current market headwinds, there have been numerous positive strategic developments across the group over the last year that make Alumasc well positioned to continue its recent underlying growth trajectory over the medium to longer term. The level of specifications and the value of pre-order pipelines remain strong across the group, particularly Levolux's relatively new business streams of North American Solar Shading & Screening and UK Balconies & Balustrading where market share is growing rapidly from a low base. 

The Board continues to have confidence in the future growth prospects of the group in view of:

· The strategic positioning of our businesses in specialist growth markets;

· The consistent investment in recent years in growth resources and additional capacity, including the successful commissioning of the new Timloc factory in January;

· Levolux and Alumasc Water Management's potential to further develop export markets; and

· The recent acquisition of Wade, a high-quality business with development and synergy potential.

 

Enquiries:

The Alumasc Group plc

Paul Hooper (Chief Executive) 01536 383821

Andrew Magson (Finance Director) 01536 383844

 

Glenmill Partners Limited

Simon Bloomfield 07771 758514

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFFTVRIVLIT
Date   Source Headline
6th Feb 20184:59 pmRNSDirector/PDMR Shareholding
1st Feb 20187:00 amRNSAcquisition
1st Feb 20187:00 amRNSHalf-year Report
26th Jan 20187:00 amRNSCompany Secretary Change
27th Oct 201711:17 amRNSResult of AGM
26th Oct 20177:00 amRNSAGM Statement
24th Oct 201711:06 amRNSDirector/PDMR Shareholding
17th Oct 20174:11 pmRNSDirector/PDMR Shareholding
17th Oct 20174:07 pmRNSDirector/PDMR Shareholding
14th Sep 201711:11 amRNSDirector/PDMR Shareholding
12th Sep 20174:54 pmRNSDirector/PDMR Shareholding
6th Sep 20179:44 amRNSHolding(s) in Company
5th Sep 20177:00 amRNSFinal Results
12th Jul 20172:22 pmRNSNotice of Results
28th Jun 20179:43 amRNSDirector/PDMR Shareholding
20th Jun 201712:48 pmRNSDirector/PDMR Shareholding
12th May 20179:39 amRNSDirector/PDMR Shareholding
28th Apr 20171:06 pmRNSDirector/PDMR Shareholding
10th Apr 20174:10 pmRNSHolding(s) in Company
10th Apr 20174:06 pmRNSHolding(s) in Company
29th Mar 20175:01 pmRNSDirector/PDMR Shareholding
13th Mar 20179:23 amRNSDirector/PDMR Shareholding
1st Mar 20179:02 amRNSDirector/PDMR Shareholding
21st Feb 20177:00 amRNS£5m contract wins
17th Feb 20172:10 pmRNSDirector/PDMR Shareholding
31st Jan 20177:00 amRNSHalf-year Report
23rd Jan 201710:35 amRNSDirector/PDMR Shareholding
6th Jan 20177:00 amRNSInterim results announcement date
5th Dec 20163:34 pmRNSHolding(s) in Company
14th Nov 201610:13 amRNSDirector/PDMR Shareholding
10th Nov 20168:59 amRNSDirector/PDMR Shareholding
7th Nov 20163:41 pmRNSDirector/PDMR Shareholding
4th Nov 20168:21 amRNSDirector/PDMR Shareholding
28th Oct 201611:02 amRNSResult of AGM
28th Oct 201610:28 amRNSNotice of Results
27th Oct 20167:00 amRNSAGM Trading Statement
18th Oct 20169:26 amRNSHolding(s) in Company
27th Sep 20163:10 pmRNSDirector/PDMR Shareholding
27th Sep 20163:08 pmRNSDirector/PDMR Shareholding
9th Sep 20161:41 pmRNSDirector/PDMR Shareholding
8th Sep 20163:09 pmRNSAmendment - Holding(s) in Company
7th Sep 201612:02 pmRNSHolding(s) in Company
2nd Sep 201612:59 pmRNSHolding(s) in Company
1st Sep 20167:00 amRNSFinal Results
26th Jul 201611:04 amRNSHolding(s) in Company
20th Jul 20167:00 amRNSNotice of Results
12th Jul 20169:13 amRNSHolding(s) in Company
5th Jul 201610:09 amRNSDirector/PDMR Shareholding
1st Jul 20163:31 pmRNSDirector/PDMR Shareholding
30th Jun 20164:50 pmRNS£4m sale of Dyson Diecastings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.